-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Celestica, Lowers Price Target to $430

Benzinga·07/29/2026 12:07:08
Listen to the news
Barclays analyst Tim Long maintains Celestica (NYSE:CLS) with a Overweight and lowers the price target from $441 to $430.